Modulating the Thermoresponse of Polymer-Protein Conjugates with Hydrogels for Controlled Release

Sustained release is being explored to increase plasma and tissue residence times of polymer-protein therapeutics for improved efficacy. Recently, poly(oligo(ethylene glycol) methyl ether methacrylate) (PEGMA) polymers have been established as potential PEG alternatives to further decrease immunogenicity and introduce responsive or sieving properties. We developed a drug delivery system that locally depresses the lower critical solution temperature (LCST) of PEGMA-protein conjugates within zwitterionic hydrogels for controlled release. Inside the hydrogel the conjugates partially aggregate through PEGMA-PEGMA chain interactions to limit their release rates, whereas conjugates outside of the hydrogel are completely solubilized. Release can therefore be tuned by altering hydrogel components and the PEGMA’s temperature sensitivity without the need for traditional controlled release mechanisms such as particle encapsulation or affinity interactions. Combining local LCST depression technology and degradable zwitterionic hydrogels, complete release of the conjugate was achieved over 13 days.

Yeast Particle Encapsulation of Scaffolded Terpene Compounds for Controlled Terpene Release

Terpenes are naturally occurring compounds produced by plants that are of great commercial interest in the food, agricultural, cosmetic, and pharmaceutical industries due to their broad spectra of antibacterial, antifungal, anthelmintic, membrane permeation enhancement, and antioxidant biological activities. Applications of terpenes are often limited by their volatility and the need for surfactants or alcohols to produce stable, soluble (non-precipitated) products. Yeast particles (YPs) are hollow, porous microspheres that have been used for the encapsulation of terpenes (YP terpenes) by passive diffusion of terpenes through the porous YP cell walls. We here report the development of a second generation YP encapsulated terpene technology that incorporates the stimuli-responsive control of terpene release using biodegradable pro-terpene compounds (YP pro-terpenes). YP terpenes and YP pro-terpenes were both produced, in which high levels of carvacrol, eugenol, thymol and geraniol were encapsulated. The YP pro-terpenes show higher encapsulation stability than YP terpenes due to pro-terpenes being non-volatile solids at room temperature and stable in suspensions at neutral pH. YP pro-terpenes and YP terpenes were evaluated for biological activity in antibacterial, antifungal and anthelmintic assays. The YP pro-terpenes retained the full biological activity of the parent terpene compound.

Controlled viscoelastic particle encapsulation in microfluidic devices

The encapsulation of particles in droplets using microfluidic devices finds application across several fields ranging from biomedical engineering to material science. The encapsulation process, however, is often affected by poor...

Particle encapsulation in aqueous ferrofluid drops and sorting of particle-encapsulating drops from empty drops using a magnetic field

Handling and manipulation of particle-encapsulating droplets (PED) have profound applications in biochemical assays. Herein we report encapsulation of microparticles in aqueous ferrofluid droplets in a primary continuous phase (CP) and...

Effect of Polyvinyl Acetate Stabilization on the Swelling-Shrinkage Properties of Expansive Soil

Polyvinyl acetate constitutes a class of polymers that can entirely dissolve in water to form a solution. In this study, polyvinyl acetate as a nontraditional chemical stabilizer was used in soil improvement. Laboratory tests were carried out to evaluate the effect of polyvinyl acetate on swelling-shrinkage properties of expansive soil. A series of shrink/swell tests were performed with adding polyvinyl acetate as amendment at a concentration 3 g/cm3 to four aggregate sizes in the range of 0–0.5 mm, 0.5–1 mm, 1-2 mm, and 2–5 mm and five concentrations 1.5 g/cm3, 3 g/cm3, 4.5 g/cm3, 6 g/cm3, and 9 g/cm3 to soils with aggregate size in the range of 0.5–1 mm for comparison of results with those of untreated soils. The results show that all the linear swelling ratio (LSWR) and linear shrinkage ratio (LSHR) values of the treated specimens decrease. SEM images and the test results indicate the achieved reduction in volume change of the soil tested using soil pore filling and particle encapsulation.